pyrrolidonecarboxylic acid and Attention Deficit Disorder with Hyperactivity

pyrrolidonecarboxylic acid has been researched along with Attention Deficit Disorder with Hyperactivity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adler, LA; Faraone, SV; Manor, I; Newcorn, JH1
Adler, LA; Daniely, Y; Manor, I; Rubin, J1
Buoli, M; Cahn, W; Serati, M1
Adler, LA; Aharon-Peretz, J; Ben-Hayun, R; Biederman, J; Daniely, Y; Manor, I; Megiddo, D; Newcorn, JH; Salomy, D; Weizman, A1

Reviews

1 review(s) available for pyrrolidonecarboxylic acid and Attention Deficit Disorder with Hyperactivity

ArticleYear
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
    Expert review of neurotherapeutics, 2016, Volume: 16, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents

2016

Trials

3 trial(s) available for pyrrolidonecarboxylic acid and Attention Deficit Disorder with Hyperactivity

ArticleYear
Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder.
    Postgraduate medicine, 2013, Volume: 125, Issue:4

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psychological Tests; Pyridoxine; Pyrrolidonecarboxylic Acid; Treatment Outcome; Young Adult

2013
Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD.
    Postgraduate medicine, 2014, Volume: 126, Issue:5

    Topics: Adolescent; Adult; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Executive Function; Female; Humans; Male; Middle Aged; Pyridoxine; Pyrrolidonecarboxylic Acid; Young Adult

2014
A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Age of Onset; Attention Deficit Disorder with Hyperactivity; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyridoxine; Pyrrolidonecarboxylic Acid

2012